John Owen Brennan, Director at ImmunityBio, Inc. (IBRX), bought 25,000 shares at $2.74 ($71K) on 2023-06-02, disclosed to the SEC on 2023-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 5,000 | $14K | 19.4% |
| 2 | $2.80 | 10,000 | $28K | 39.6% |
| 3 | $2.90 | 10,000 | $29K | 41.0% |
| Total | $2.83 avg | 25,000 | $71K | 100% |